The Patent Finder

Terms ending in 2043

Pfizer Inc.

Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,655,161Solid Forms of an eIF4E Inhibitor
In force
 · High confidence
SJP Biotec GmbHIn forceHigh confidence
US 12,577,240Antiviral Heteroaryl Ketone Derivatives
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,297,190Modulators of STING (Stimulator of Interferon Genes)
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,649,933Cells Having Gene Duplications and Uses Thereof
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,622,968Formulation for Oral Delivery of Proteins, Peptides and Small Molecules with Poor Permeability
In force
 · High confidence
Pfizer Ireland PharmaceuticalsIn forceHigh confidence
US 12,539,304Combination of an Anaplastic Lymphoma Kinase Inhibitor and a Cyclin Dependent Kinase Inhibitor
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,667,671System and Method for Information Management in Computerized Injectors
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,545,669Cycloalkyl and Heterocycloalkyl Benzisoxazole Sulfonamide Derivatives
In force
 · High confidence
CTXT Pty Ltd.In forceHigh confidence
US 12,734,231Cell culture process for producing RSV F protein
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,569,487Treatment of Hidradenitis with Jak Inhibitors
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
5 more term ends in 2043 · Pro
10 of 15 patents shown. Soonest term end first, then patent number.
Pro members see all 15.
Upgrade to Pro
13 of these are in force and held by Pfizer Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited